GeNouRoB

Laval, France Founded: 2007 • Age: 19 yrs
Medical devices to measure knee ligament laxity and enhance rehabilitation
Request Access

About GeNouRoB

GeNouRoB is a company based in Laval (France) founded in 2007.. GeNouRoB has raised $417.81 thousand across 4 funding rounds from investors including Siparex, GO CAPITAL and European Union. GeNouRoB offers products and services including GNRB, DYNEELAX, and SPINEO. GeNouRoB operates in a competitive market with competitors including Trice Medical, Edge Surgical, OrthoScan, Onicorp and Bone Index Finland, among others.

  • Headquarter Laval, France
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $417.81 K (USD)

    in 4 rounds

  • Latest Funding Round
    $55.05 K (USD), Grant

    Nov 30, 2019

  • Investors
    Siparex

    & 3 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of GeNouRoB

GeNouRoB offers a comprehensive portfolio of products and services, including GNRB, DYNEELAX, and SPINEO. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Device for automated knee laxity and ACL injury assessment.

Motorized tool for precise ligament analysis and diagnostics.

Patented device for spine therapy and back pain management.

Funding Insights of GeNouRoB

GeNouRoB has successfully raised a total of $417.81K across 4 strategic funding rounds. The most recent funding activity was a Grant round of $55.05 thousand completed in November 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Grant — $55,048
  • First Round

    (01 Jun 2011)

  • Investors Count 4
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2019 Amount Grant - GeNouRoB Valuation

investors

Jul, 2019 Amount Grant - GeNouRoB Valuation

investors

May, 2015 Amount Seed - GeNouRoB Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in GeNouRoB

GeNouRoB has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Siparex, GO CAPITAL and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Government agency and accelerator focusing on innovative startups and SMEs
Founded Year Domain Location
Private equity investments are focused on growth stage companies.
Founded Year Domain Location
Private equity investments are directed toward multiple sectors.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by GeNouRoB

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - GeNouRoB

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Genourob Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of GeNouRoB

GeNouRoB operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Trice Medical, Edge Surgical, OrthoScan, Onicorp and Bone Index Finland, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Needle-based visualization devices for orthopedic diagnostics are developed.
domain founded_year HQ Location
Digital depth gauges for orthopedic bone measurements are supplied.
domain founded_year HQ Location
Mini C-arms for orthopedic imaging are developed by OrthoScan.
domain founded_year HQ Location
MRI systems for extremity imaging are developed and marketed.
domain founded_year HQ Location
Ultrasound-based POC device for osteoporosis screening is developed.
domain founded_year HQ Location
Robotic surgical systems for orthopedic treatments are provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Genourob

Frequently Asked Questions about GeNouRoB

When was GeNouRoB founded?

GeNouRoB was founded in 2007 and raised its 1st funding round 4 years after it was founded.

Where is GeNouRoB located?

GeNouRoB is headquartered in Laval, France.

Is GeNouRoB a funded company?

GeNouRoB is a funded company, having raised a total of $417.81K across 4 funding rounds to date.

What does GeNouRoB do?

Founded in 2007 in Laval, France, the company focuses on the medical devices sector. Devices and associated software are designed, produced, and marketed for assessing knee ligament structures and performance. Automated dynamic laximetry tools are utilized to measure laxity through standardized tests. Products are distributed in over 18 countries, supporting clinical evaluations and rehabilitation processes.

Who are the top competitors of GeNouRoB?

GeNouRoB's top competitors include Edge Surgical, Trice Medical and Echolight Medical.

What products or services does GeNouRoB offer?

GeNouRoB offers GNRB, DYNEELAX, and SPINEO.

Who are GeNouRoB's investors?

GeNouRoB has 4 investors. Key investors include Siparex, GO CAPITAL, European Union, and EIC Fund.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available